Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans.

Use of ELISpot assay to study HBs-specific B cell responses in vaccinated and HBV infected humans.
复制标题

使用 ELISpot 测定研究接种疫苗和 HBV 感染人群中 HBs 特异性 B 细胞反应

DOI:
10.1038/s41426-018-0034-0
复制
发表时间:
2018-02-16
影响因子:
13.2
通讯作者:
Wu C
Wu C
中科院分区:
医学2区
文献类型:
--
作者:
Tian C;Chen Y;Liu Y;Wang S;Li Y;Wang G;Xia J;Zhao XA;Huang R;Lu S;Wu C

文献摘要

参考文献

被引文献

相似文献

乙型肝炎表面抗体(HBsAb)在预防乙型肝炎病毒(HBV)感染中起着至关重要的作用,文献对其进行了广泛研究。与此同时,在接种者和HBV感染者中乙型肝炎表面抗原(HBs)特异性B细胞的状况得到的关注有限。在目前的研究中,我们采用了高度特异性的B细胞酶联免疫点(ELISpot)检测来分析各种临床环境中的乙型肝炎特异性B细胞:在接受额外HBV疫苗增强之前和之后有HBV疫苗接种史的健康个体,处于不同临床阶段的慢性HBV感染者,接受或不接受特定类型的抗病毒治疗,或是否接受了一剂HBV疫苗。在所有这些病例中,B细胞ELISpot法被有效地用于枚举hbs特异性B细胞的频率。虽然当前报告的重点是建立这种检测方法在HBV研究中的实用性,但在这项基于HBV特异性B细胞在各种条件下的概况和动态的初步研究中,进行了许多有趣的观察。这些信息有助于指导未来设计针对慢性乙型肝炎的新治疗策略。
Hepatitis B surface antibody (HBsAb) plays a critical role in protecting against infection of hepatitis B virus (HBV) and were extensively studied in literature. At the same time, the status of hepatitis B surface antigen (HBs)-specific B cells in both vaccinated and HBV infected people received limited attention. In the current study, we adopted a highly specific B-cell Enzyme Linked ImmunoSpot (ELISpot) assay to analyze HBs-specific B cells in various clinical settings: healthy individuals with the history of HBV vaccination before and after receiving an extra HBV vaccine boost, people chronically infected with HBV (CHB) in various clinical stages, with or without a particular type anti-viral treatment, or whether receiving a dose of HBV vaccine. In all of these cases, B-cell ELISpot assay was used effectively in enumerating the frequency of HBs-specific B cells. While the focus of the current report was to establish the utility of this assay for HBV research, a number of interesting observations were made in this pilot study based on the profiles and dynamics of HBs-specific B cells in various conditions. Such information is useful to guide the future work in designing novel therapeutic strategies against CHB.
DOI: 10.3389/fimmu.2012.00078
发表时间: 2012
影响因子: 7.3
作者:
Fink K
通讯作者: Fink K
DOI: 10.1016/0022-1759(83)90308-3
发表时间: 1983-01-01
影响因子: 2.2
作者:
CZERKINSKY, CC;NILSSON, LA;TARKOWSKI, A
通讯作者: TARKOWSKI, A
DOI: 10.3748/wjg.v20.i20.6262
发表时间: 2014-05-28
影响因子: 4.3
作者:
Tang, Ceen-Ming;Yau, Tung On;Yu, Jun
通讯作者: Yu, Jun
DOI: 10.1093/cid/ciu589
发表时间: 2014-12-01
影响因子: 11.8
作者:
Lucia, Marc;Crespo, Elena;Bestard, Oriol
通讯作者: Bestard, Oriol
DOI: 10.1016/s0140-6736(14)60220-8
发表时间: 2014-12-06
期刊: LANCET
影响因子: 168.9
作者:
Trepo, Christian;Chan, Henry L. Y.;Lok, Anna
通讯作者: Lok, Anna